Clinical Trial

Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two Interventions

Completed
View on ClinicalTrials.gov →
Summary
Atopic dermatitis is a chronic inflammatory skin disease characterized by eczematous skin lesions and pruritus. This partially randomized, three-arm pilot feasibility study was designed to evaluate two adjunctive group psychotherapy interventions in adults with moderate-to-severe atopic dermatitis receiving standard dermatological care. Participants were assigned to one of three study arms: treatment as usual alone, treatment as usual plus atopic dermatitis-specific cognitive behavioural and schema mode group therapy, or treatment as usual plus stress management and resilience group therapy. The psychotherapy interventions consisted of weekly group sessions during a 14-week intervention period. Assessments were scheduled at baseline, post-intervention at week 14, and six-month follow-up. Disease severity was assessed using the Eczema Area and Severity Index and SCORing Atopic Dermatitis.
Trial Details
NCT Number NCT07599878
Lead Sponsor Semmelweis University
Conditions Atopic Dermatitis
Enrollment 32 participants
Start Date 2022-09-05
Primary Completion 2023-07-10 (estimated)
Study Completion 2023-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-20